The anatomy of t-cell mediated neutrophil recruitment during lung infection
Active Project Grant Awarded
- Award ID
- R21AI191650
- Recipient
-
University Of Massachusetts Medical School UEI MQE2JHHJW9Q8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $472,210
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 69% complete
- Place of performance
- Worcester, MA 01655, USA
Award details come from USAspending.gov.
About this award
The University of Massachusetts Medical School received a $472,210 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective June 23, 2025, through May 31, 2027. The grant supports biomedical research investigating T-cell mediated neutrophil recruitment during lung infection, with specific focus on understanding how prior respiratory pathogen exposure influences subsequent pneumonia susceptibility. The research examines the spatiotemporal relationship between lung-resident CD4+ memory T cells and neutrophil emigration patterns during pneumonia, while developing a transcriptional atlas of key cellular signaling networks that drive accelerated immune responses in previously exposed lungs.
The project addresses a significant knowledge gap in host defense mechanisms during pneumonia—a leading cause of morbidity and mortality worldwide—by delineating when, where, and how prior respiratory infection experience influences disease susceptibility to related pathogens. The research employs novel experimental approaches, including a crystal ribcage technique for investigating neutrophil recruitment dynamics, to advance understanding of location-dependent immune protection and heterotypic immunity in the pulmonary system. Deliverables include scientific findings, experimental methodologies, and transcriptional datasets that will inform clinical intervention strategies for patients at risk of pneumonia.
Description
- Abstract
- Pneumonia is a leading cause of morbidity and mortality worldwide. Microbes that cause respiratory infections are encountered by virtually everyone, but effective immunity in healthy individuals typically prevents such exposures from progressing to pneumonia. Yet, host signals guiding lung defense constitute a major knowledge GAP, limiting opportunities for clinical intervention in patients at risk for pneumonia. A goal of our research is to delineate when, where, and how prior experience with respiratory pathogens influences pneumonia susceptibility thereafter. Recovery from lung infections elicits strong and rapid protection in response to a subsequent challenge with related but distinct organisms (e.g., different strains/serotypes). We and others have demonstrated that this heterotypic protection is location-dependent, restricted to the previously exposed region and independent of circulating factors. Moreover, accelerated immunity in experienced lungs requires lung CD4+ resident memory t (TRM) cells, which accumulate in the interstitium near bronchovascular bundles and pulmonary veins. CD4+ t cells are required for the rapid and protective neutrophil response observed in experienced lungs, and our pilot studies, using a novel crystal ribcage approach to connect experienced lungs to the circulation of naïve mice, indicate that this is specifically driven by lung-localized CD4+ TRM cells. Excitingly, this same approach revealed neutrophil recruitment as remote as subpleural alveoli in as few as 4HRS in the experienced lung, demanding a better understanding of the multi- cellular signaling network tethering CD4+ TRM cells to enhanced neutrophilic defense. The primary objectives of this proposal are to determine the spatiotemporal relationship between centrally concentrated CD4+ TRM cells and emigrated neutrophils during pneumonia, while developing a transcriptional atlas of key immune processes corresponding with enhanced defense in the experienced lung. To do so, we will test the hypotheses that: 1) infection of the experienced lung activates CD4+ t cells in the interstitium of bronchovascular bundles and pulmonary veins, coinciding with diffusely parenchymal neutrophil recruitment; and 2) CD4+ t cells in the experienced lung trigger rapid, diffuse, and heterogeneous transcriptome changes across diverse distal lung and immune cells. This will be accomplished using state-of-the-art approaches for imaging, cytometry, and spatial transcriptomics, leveraging expertise and resources across two neighboring institutions. Results from this study will provide key insights about the cells and signals dictating host immunity. Furthermore, data from the proposed experiments will provide a foundation for future investigations by our groups and others, having a lasting impact on the field.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Trustees Of Boston University | $216,205 |
Quick answers
Who received award R21AI191650?
R21AI191650 was awarded to University Of Massachusetts Medical School by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 23, 2025.
How much is award R21AI191650 worth?
$472,210 has been obligated on R21AI191650.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award